About this trial
In the present semi-crossover randomized design, 15 recreationally active young adults (19-40 y) will receive stable isotope tracer infusions and perform a single bout of resistance exercise. Immediately after exercise, participants will ingest either 1 medium russet potato with skins and 2 ounce-equivalent lean ground beef combination (274 kcals, 19.3 g protein, 5 g fat, 37 g carbohydrates, and 4 g fiber), 2 slices of white bread and beef combination (262 kcals, 19.8 g protein, 6.8 g fat, 28 g carbohydrates, and 1.8 g fiber) or 2 ounce-equivalent beef (93% lean meat/7% fat; 110 kcals, 14.8 g protein, and 5 g fat). Repeated blood and muscle biopsies will be collected to determine whole body leucine kinetics, amino acid concentrations, anabolic signaling and myofibrillar protein synthesis rates during the trials.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age 19-40 yrs
Pre-menopausal
Recreationally-active
Weight stable for prior 6 months
Disqualifiers
Age outside of range (20 - 35 yrs)
Pregnancy
Irregular menstrual cycles (i.e., ~21 day or ~35 day cycle)
Participation in previous research using L-[1-13C] leucine and L-[ring-2H5] phenylalanine
Trial design
Crossover
Treatments tested in this trial
Resistance Exercise
BehavioralParticipants will perform leg press and leg extension immediately prior to ingestion of either potato-beef combination, bread-beef combination, or beef alone.
Potato and Beef
Dietary supplementParticipants will ingest baked russet potato and cooked ground beef immediately after resistance exercise.
Bread and Beef
Dietary supplementParticipants will ingest white bread and cooked ground beef immediately after resistance exercise.
Beef
Dietary supplementParticipants will ingest cooked ground beef immediately after resistance exercise.
Treatment groups
Trial outcomes
Primary outcomes
Myofibrillar protein fractional synthesis rate
Myofibrillar protein synthesis rates will be assessed during the postabsorptive and postprandial periods of experimental primed-constant stable isotope infusions.
Whole body leucine kinetics
Whole body leucine kinetics will be determined via breath sample collection during the postabsorptive and postprandial periods of experimental primed-constant stable isotope infusions and analyzed via LC/MS/MS.
Secondary outcomes
Activation of anabolic signaling targets
Phosphorylation of mTOR-dependent anabolic signaling targets (i.e., 4E-BP1, S6K1, and rps) will be assessed via Western Blotting (phosphorylated-to-total ratio).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.